A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome

NCT01981525 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Li-Fraumeni Syndrome

Interventions

DRUG: Metformin

Sponsor

National Cancer Institute (NCI)